These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
133 related articles for article (PubMed ID: 16794245)
1. Liposomal doxorubicin, cyclophosphamide, and etoposide and antiretroviral therapy for patients with AIDS-related lymphoma: a pilot study. Combs S; Neil N; Aboulafia DM Oncologist; 2006 Jun; 11(6):666-73. PubMed ID: 16794245 [TBL] [Abstract][Full Text] [Related]
2. Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response. Levine AM; Tulpule A; Espina B; Sherrod A; Boswell WD; Lieberman RD; Nathwani BN; Welles L J Clin Oncol; 2004 Jul; 22(13):2662-70. PubMed ID: 15226333 [TBL] [Abstract][Full Text] [Related]
3. Acquired immunodeficiency syndrome-related lymphoma: simultaneous treatment with combined cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy and highly active antiretroviral therapy is safe and improves survival--results of the German Multicenter Trial. Weiss R; Mitrou P; Arasteh K; Schuermann D; Hentrich M; Duehrsen U; Sudeck H; Schmidt-Wolf IG; Anagnostopoulos I; Huhn D Cancer; 2006 Apr; 106(7):1560-8. PubMed ID: 16502436 [TBL] [Abstract][Full Text] [Related]
4. Phase II trial of CHOP plus rituximab in patients with HIV-associated non-Hodgkin's lymphoma. Boué F; Gabarre J; Gisselbrecht C; Reynes J; Cheret A; Bonnet F; Billaud E; Raphael M; Lancar R; Costagliola D J Clin Oncol; 2006 Sep; 24(25):4123-8. PubMed ID: 16896005 [TBL] [Abstract][Full Text] [Related]
5. Safety and efficacy of cyclophosphamide, adriamycin, vincristine, prednisone and rituximab in patients with human immunodeficiency virus-associated diffuse large B-cell lymphoma: results of a phase II trial. Ribera JM; Oriol A; Morgades M; González-Barca E; Miralles P; López-Guillermo A; Gardella S; López A; Abella E; García M; Br J Haematol; 2008 Feb; 140(4):411-9. PubMed ID: 18162120 [TBL] [Abstract][Full Text] [Related]
6. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease. Gabarre J; Marcelin AG; Azar N; Choquet S; Lévy V; Lévy Y; Tubiana R; Charlotte F; Norol F; Calvez V; Spina M; Vernant JP; Autran B; Leblond V Haematologica; 2004 Sep; 89(9):1100-8. PubMed ID: 15377471 [TBL] [Abstract][Full Text] [Related]
7. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. Re A; Cattaneo C; Michieli M; Casari S; Spina M; Rupolo M; Allione B; Nosari A; Schiantarelli C; Vigano M; Izzi I; Ferremi P; Lanfranchi A; Mazzuccato M; Carosi G; Tirelli U; Rossi G J Clin Oncol; 2003 Dec; 21(23):4423-7. PubMed ID: 14581441 [TBL] [Abstract][Full Text] [Related]
8. A prospective, non-randomised phase 1-2 trial of VACOP-B with filgrastim support for HIV-related non-Hodgkin's lymphoma. Sawka CA; Shepherd FA; Franssen E; Brandwein J; Dotten DA; Routy JP; Walker IR; St-Louis J; Taylor M; Arts K; Crump M; Foote M Biotechnol Annu Rev; 2005; 11():381-9. PubMed ID: 16216784 [TBL] [Abstract][Full Text] [Related]
9. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Wang ES; Straus DJ; Teruya-Feldstein J; Qin J; Portlock C; Moskowitz C; Goy A; Hedrick E; Zelenetz AD; Noy A Cancer; 2003 Sep; 98(6):1196-205. PubMed ID: 12973843 [TBL] [Abstract][Full Text] [Related]
10. Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study. Simcock M; Blasko M; Karrer U; Bertisch B; Pless M; Blumer L; Vora S; Robinson JO; Bernasconi E; Terziroli B; Moirandat-Rytz S; Furrer H; Hirschel B; Vernazza P; Sendi P; Rickenbach M; Bucher HC; Battegay M; Koller MT; Antivir Ther; 2007; 12(6):931-9. PubMed ID: 17926647 [TBL] [Abstract][Full Text] [Related]
11. Report of AIDS-related lymphoma in South Korea. Kim JS; Kim SJ; Kim JS; Kim ES; Shin HJ; Chung JS; Min YH; Lee MH; Choi YJ; Bang SM; Kim JA; Cho GJ; Chi HS; Jang SS; Park CJ; Suh C; Park CW; Kim CS; Jpn J Clin Oncol; 2008 Feb; 38(2):134-9. PubMed ID: 18263652 [TBL] [Abstract][Full Text] [Related]
12. Serbian lymphoma study group (SLG): the prognosis of AIDS-related non-Hodgkin's lymphoma. Djunic I; Jevtovic DL; Ranin J; Salemovic D; Tomin D; Mihaljevic B Biomed Pharmacother; 2008 Jan; 62(1):12-5. PubMed ID: 17629445 [TBL] [Abstract][Full Text] [Related]
13. Dexamethasone, cyclophosphamide, etoposide and cisplatin (DCEP) for relapsed or refractory multiple myeloma patients. Dadacaridou M; Papanicolaou X; Maltesas D; Megalakaki C; Patos P; Panteli K; Repousis P; Mitsouli-Mentzikof C J BUON; 2007; 12(1):41-4. PubMed ID: 17436400 [TBL] [Abstract][Full Text] [Related]
14. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas. Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557 [TBL] [Abstract][Full Text] [Related]
16. Pilot trial of infusional cyclophosphamide, doxorubicin, and etoposide plus didanosine and filgrastim in patients with human immunodeficiency virus-associated non-Hodgkin's lymphoma. Sparano JA; Wiernik PH; Hu X; Sarta C; Schwartz EL; Soeiro R; Henry DH; Mason B; Ratech H; Dutcher JP J Clin Oncol; 1996 Nov; 14(11):3026-35. PubMed ID: 8918501 [TBL] [Abstract][Full Text] [Related]
17. A pilot study of epratuzumab and rituximab in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy in patients with previously untreated, diffuse large B-cell lymphoma. Micallef IN; Kahl BS; Maurer MJ; Dogan A; Ansell SM; Colgan JP; Geyer S; Inwards DJ; White WL; Habermann TM Cancer; 2006 Dec; 107(12):2826-32. PubMed ID: 17099879 [TBL] [Abstract][Full Text] [Related]
18. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). Sparano JA; Lee S; Chen MG; Nazeer T; Einzig A; Ambinder RF; Henry DH; Manalo J; Li T; Von Roenn JH J Clin Oncol; 2004 Apr; 22(8):1491-500. PubMed ID: 15084622 [TBL] [Abstract][Full Text] [Related]
19. [Recommendations from the GESIDA/Spanish AIDS Plan regarding antiretroviral treatment in adults with human immunodeficiency virus infection (update February 2009)]. Panel de expertos de Gesida y Plan Nacional sobre el Sida Enferm Infecc Microbiol Clin; 2009 Apr; 27(4):222-35. PubMed ID: 19246124 [TBL] [Abstract][Full Text] [Related]
20. Plasma HHV-8 viral load in HHV-8-related lymphoproliferative disorders associated with HIV infection. Simonelli C; Tedeschi R; Gloghini A; Talamini R; Bortolin MT; Berretta M; Spina M; Morassut S; Vaccher E; De Paoli P; Carbone A; Tirelli U J Med Virol; 2009 May; 81(5):888-96. PubMed ID: 19319955 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]